Medium chain triglyceride    (DrugBank: Medium chain triglyceride)

1 disease
IDDisease name (Link within this page)Number of trials
318Citrin deficiency1

318. Citrin deficiency    [ 2 clinical trials,   2 drugs,   (DrugBank: 2 drugs),   0 drug target gene,   0 drug target pathway]
Searched query = "Citrin deficiency", "NICCD", "Adult-onset type II citrullinemia", "CTLN2"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-jRCTs041190017
31/07/201210/04/2019Confirmation of effects of medium chain triglyceride therapy for citrin deficiencyConfirmation of effects of medium chain triglyceride therapy for citrin deficiency, especially in patients with symptomatic post neonatal intrahepatic cholestasis and that with adult-onset type II citrullinemia citrin deficiency
Endocrinology and Metabolism, Pediatrics;D006111
Medium chain triglyceride 5-15ml 3 times a dayMitsui TetsuoNULLRecruitingNot applicable80ageBoth50Phase 2Japan